LianBio Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep '23 Sep 30, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Selling, General & Admin	68.89	67.81	38.21	14.54	4.15
Research & Development	37.67	57.54	157.36	120.33	54.26
Operating Expenses	106.56	125.35	195.57	134.87	58.41
Operating Income	-106.56	-125.35	-195.57	-134.87	-58.41
Interest Expense	-	-	-	-4.85	-
Interest & Investment Income	8.34	2.71	0.22	-	0.03
Other Non Operating Income (Expenses)	9.5	10.41	-0.46	0.12	-0
EBT Excluding Unusual Items	-88.71	-112.23	-195.81	-139.6	-58.38
Gain (Loss) on Sale of Investments	1.61	1.61	0.02	-	-
Pretax Income	-87.11	-110.62	-195.78	-139.6	-58.38
Income Tax Expense	0.87	-0.33	0.52	0	0.01
Net Income	-87.98	-110.29	-196.3	-139.6	-58.39
Net Income to Common	-87.98	-110.29	-196.3	-139.6	-58.39
Shares Outstanding (Basic)	107	108	34	12	5
Shares Outstanding (Diluted)	107	108	34	12	5
Shares Change (YoY)	7.54%	213.78%	185.40%	147.34%	-
EPS (Basic)	-0.82	-1.02	-5.71	-11.58	-11.98
EPS (Diluted)	-0.82	-1.02	-5.71	-11.58	-11.98
Free Cash Flow	-83.99	-101.03	-164.9	-99.03	-28.08
Free Cash Flow Per Share	-0.78	-0.94	-4.79	-8.22	-5.76
EBITDA	-105.26	-124.35	-195.05	-134.79	-
D&A For EBITDA	1.3	1.01	0.53	0.08	-
EBIT	-106.56	-125.35	-195.57	-134.87	-58.41

Updated Nov 13, 2023. Source: S&P Global Market Intelligence. Standard template. Financial Sources.